CN112753776A - 一种保护肠胃的奶粉及其制备方法 - Google Patents
一种保护肠胃的奶粉及其制备方法 Download PDFInfo
- Publication number
- CN112753776A CN112753776A CN202110112958.XA CN202110112958A CN112753776A CN 112753776 A CN112753776 A CN 112753776A CN 202110112958 A CN202110112958 A CN 202110112958A CN 112753776 A CN112753776 A CN 112753776A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- powder
- stomach
- parts
- intestines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 163
- 235000013336 milk Nutrition 0.000 title claims abstract description 60
- 239000008267 milk Substances 0.000 title claims abstract description 60
- 210000004080 milk Anatomy 0.000 title claims abstract description 60
- 210000000936 intestine Anatomy 0.000 title claims abstract description 51
- 210000002784 stomach Anatomy 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000002131 composite material Substances 0.000 claims abstract description 34
- 239000006041 probiotic Substances 0.000 claims abstract description 29
- 230000000529 probiotic effect Effects 0.000 claims abstract description 29
- 235000018291 probiotics Nutrition 0.000 claims abstract description 29
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 22
- 239000008101 lactose Substances 0.000 claims abstract description 22
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 22
- 235000008939 whole milk Nutrition 0.000 claims abstract description 21
- 241000283690 Bos taurus Species 0.000 claims abstract description 20
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 20
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 20
- 240000008042 Zea mays Species 0.000 claims abstract description 20
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 20
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 20
- 210000003022 colostrum Anatomy 0.000 claims abstract description 20
- 235000021277 colostrum Nutrition 0.000 claims abstract description 20
- 235000005822 corn Nutrition 0.000 claims abstract description 20
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 20
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 20
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 20
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 20
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 20
- 239000007787 solid Substances 0.000 claims abstract description 20
- 239000006188 syrup Substances 0.000 claims abstract description 20
- 235000020357 syrup Nutrition 0.000 claims abstract description 20
- 229960003080 taurine Drugs 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 230000002496 gastric effect Effects 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims description 42
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 17
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 17
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 17
- 229940088594 vitamin Drugs 0.000 claims description 15
- 229930003231 vitamin Natural products 0.000 claims description 15
- 235000013343 vitamin Nutrition 0.000 claims description 15
- 239000011782 vitamin Substances 0.000 claims description 15
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- 235000010755 mineral Nutrition 0.000 claims description 11
- -1 cidophilic Species 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 241000186000 Bifidobacterium Species 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 5
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 5
- 239000011706 ferric diphosphate Substances 0.000 claims description 5
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 5
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 5
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 5
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 5
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 5
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 5
- 229960005055 sodium ascorbate Drugs 0.000 claims description 5
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- 235000005282 vitamin D3 Nutrition 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 5
- 229940021056 vitamin d3 Drugs 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229960000342 retinol acetate Drugs 0.000 claims description 4
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 4
- 235000019173 retinyl acetate Nutrition 0.000 claims description 4
- 239000011770 retinyl acetate Substances 0.000 claims description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 4
- 229960001763 zinc sulfate Drugs 0.000 claims description 4
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 235000018102 proteins Nutrition 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 230000029087 digestion Effects 0.000 abstract description 5
- 230000008855 peristalsis Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 238000001784 detoxification Methods 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 235000021149 fatty food Nutrition 0.000 abstract description 2
- 210000004211 gastric acid Anatomy 0.000 abstract description 2
- 210000004051 gastric juice Anatomy 0.000 abstract description 2
- 238000010791 quenching Methods 0.000 abstract description 2
- 230000035922 thirst Effects 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 241001134770 Bifidobacterium animalis Species 0.000 description 12
- 229940118852 bifidobacterium animalis Drugs 0.000 description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000013872 defecation Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000018522 Gastrointestinal disease Diseases 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000011837 pasties Nutrition 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000030135 gastric motility Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000033458 reproduction Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000008384 membrane barrier Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种保护肠胃的奶粉及其制备方法，属于奶制品技术领域，包括以下重量份的原料：脱脂奶粉600‑800份，全脂奶粉150‑200份，牛初乳粉50‑100份，固体玉米糖浆2‑5份，乳糖2‑5份，低聚半乳糖1‑3份，乳铁蛋白0.3‑0.7份，牛磺酸0.2‑0.5份，复合益生菌冻干粉0.2‑2份。本发明各原料复配协同作用，添加了多种人体必需的营养元素，富含丰富的蛋白质，营养丰富，具有生津止渴、增加胃液和胃酸的分泌量，促进胃蠕动，促进脂肪类食物消化的作用，清热、润肠、解毒，具有健脾胃、保护肠胃的功效，且口感适中，丰富了人们的饮食。
Description
技术领域
本发明属于奶制品技术领域，更具体的说是涉及一种保护肠胃的奶粉及其制备方法。
背景技术
消化不良是所有肠胃不适的总称，是一种由胃动力障碍所引起的疾病，也包括胃蠕动不好的胃轻瘫和食道反流病，会反复或持续性上腹疼痛或自觉上腹不适，常在餐后加重，是消化系统疾病的一个症候群，消化不良还可能是胃、小肠或大肠出毛病的一个症状，也可能本身就是一种疾病。一般表现为进食后腹部饱胀、反酸、嗳气，食欲不振、有的患者也有恶心、呕吐、腹痛、舌苔厚腻等症状。
牛奶营养丰富、食用方便，而且物美价廉，人称“白色血液”，是最理想的天然食品。牛奶组成复杂，至少有100多种，主要成份有水、脂肪、磷脂、蛋白质、乳糖、无机盐等。牛奶中的蛋白质主要是酪蛋白、白蛋白、球蛋白、乳蛋白等，所含的20多种氨基酸中有8种是必需氨基酸，奶蛋白质是全价的蛋白质，它的消化率高达98％。乳脂肪是高质量的脂肪，品质很好，它的消化率在95％以上，而且含有大量的脂溶性维生素。奶中的乳糖是半乳糖和乳糖，是最容易消化吸收的糖类，有助于保护肠胃，牛奶还含有丰富的矿物质、钙、磷、铁、锌、铜、锰、钼，最难得的是消化系统疾病，牛奶中钙磷比例合适，非常利于钙的吸收，能够增强人体免疫力，减少肠胃疾病的发生。
益生菌是指对人体有益的微生物，肠胃病是人体的有益菌组成的菌膜屏障遭到破坏，有害菌及其分泌的毒素侵蚀肠胃黏膜，引发各种肠胃不适，益生菌能有效调理肠胃，增强肠蠕动能力，使人体始终处于菌群平衡状态，从而有效改善或缓解肠胃病带来的困扰，市场上常见的益生菌奶产品主要为发酵乳或乳饮料等液态乳制品，保质期较短，食用不方便，因此研发一种食用方便，运输方便，能够有效保护肠胃的奶粉是本领域技术人员亟需解决的问题。
发明内容
有鉴于此，本发明提供了一种保护肠胃的奶粉。
为了实现上述目的，本发明采用如下技术方案：
一种保护肠胃的奶粉，包括以下重量份的原料：脱脂奶粉600-800份，全脂奶粉150-200份，牛初乳粉50-100份，固体玉米糖浆2-5份，乳糖2-5份，低聚半乳糖1-3份，乳铁蛋白0.3-0.7份，牛磺酸0.2-0.5份，复合益生菌冻干粉0.2-2份；
上述复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，上述动物双歧杆菌的含量为1×106-1×107CFU/g，上述嗜酸乳杆菌的含量为1×106-1×107CFU/g。
本发明的有益效果：
脱脂奶粉脂肪含量很低，易消化，具有保护肠胃的作用，但是，其营养成分不均衡，因此，本发明将其和全脂奶粉复配使用，使奶粉营养成分更加均衡。
全脂奶粉蛋白质凝块细小、柔软，易于消化，本发明添加全脂奶粉作为原料之一，使本发明奶粉更易吸收。
牛初乳粉里面含有大量的免疫因子，增强人体免疫力，减少肠道疾病的发生。
固体玉米糖浆质体清亮、透明、口感温和纯正，低甜度，有麦芽香味等诸多优点。
乳铁蛋白不仅参与铁的转运，而且具有广谱抗菌、抗氧化、抗癌、调节免疫系统等强大生物功能。
乳糖中的β-双糖对肠道起到很好的一个调节作用，它利于肠道中乳酸菌等益菌群的繁殖，抑制肠道内有害菌群的生长，对人体消化系统起到一个调节的作用，利于肠道健康，同时产生丰富的B族维生素，利于促进肠道的蠕动，增加人体免疫力。
低聚半乳糖是人体肠道中双歧杆菌、嗜酸乳酸杆菌等有益菌极好的营养源和有效的增殖因子，可以改善人体肠胃的消化吸收功能。
双歧杆菌在人体肠内发酵后可产生乳酸和醋酸，能提高钙、磷、铁的利用率，促进铁和维生素D的吸收，双歧杆菌可以产生维生素B1、B2、B6、B12及丙氨酸、缬氨酸、天冬氨酸和苏氨酸等人体必需的营养物质。
嗜酸乳酸杆菌能调整肠道内菌群平衡，抑制肠道内不良微生物增殖，嗜酸乳杆菌和双歧杆菌混合组成发酵剂，在肠道内发酵后产生乳酸和醋酸，能提高钙、磷、铁的利用率，促进铁和维生素的吸收，产生维生素K和维生素B，还可以减少胆固醇的吸收，具有抑制有害细菌生长的功能，不仅能调节体内菌群失调，还能减少体内毒素的生成，减轻肝脏解毒负担。
牛磺酸具有调节体内渗透压，降血糖，提高免疫能力的功效。
本发明上述各原料复配协同作用，添加了多种人体必需的营养元素，富含丰富的蛋白质，营养丰富，具有生津止渴、增加胃液和胃酸的分泌量，促进胃蠕动，促进脂肪类食物消化的作用，清热、润肠、解毒，保护肠胃的功效，且口感适中，丰富了人们的饮食。
进一步，还包括：复合维生素，以100g上述保护肠胃的奶粉计，上述复合维生素包括：L-抗坏血酸钠25-98mg，dl-α-醋酸生育酚15-45mg，醋酸维生素A0.5-0.8mg，胆钙化醇6-12μg，盐酸吡哆醇0.8-1.5mg。
采用上述进一步技术方案的有益效果：添加复合维生素，能够维持正常生长、生殖、视觉，促进上皮组织健全及加强抗感染免疫功能；能够预防佝偻病,促进钙的吸收；能够防止奶粉中的不饱合脂肪酸发生过氧化反应,并能对皮肤有保护作用，复合维生素的添加能够提高人体免疫力，对肠胃起到保护作用。
进一步，还包括：复合矿物质，以100g上述保护肠胃的奶粉计，上述复合矿物质包括：焦磷酸铁2-4mg，硫酸锌10-15mg。
采用上述进一步技术方案的有益效果：锌、铁参与多种酶的合成与激活，对蛋白质核酸合成和肠道蛋白的消化和吸收有重要作用。
本发明还提供一种保护肠胃的奶粉的制备方法，包括以下步骤：
(1)按照上述一种保护肠胃的奶粉中各原料的重量份数和重量称取各原料；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸混合均匀，然后粉碎，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉加入预混粉中，混合均匀，制得上述保护肠胃的奶粉。
本发明的有益效果：本发明制备方法工艺简单，容易操作，生产成本低廉，适合广泛生产和应用。
进一步，上述步骤(2)为：将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸、复合矿物质混合均匀，然后粉碎，制得预混粉。
进一步，上述步骤(2)中，混合时间为20-30分钟，混合转速为50-60转/分钟。
采用上述进一步技术方案的有益效果：准确的混合参数使原料混合均匀，预混粉产品质量均一稳定。
进一步，上述步骤(2)中，粉碎至过60-70目筛。
采用上述进一步技术方案的有益效果：将原料粉碎，使奶粉品质细腻，增强口感，营养成分更容易被人体吸收。
进一步，上述步骤(3)为：将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉、复合维生素加入预混粉中，混合均匀，制得上述保护肠胃的奶粉。
进一步，上述步骤(3)中，混合时间为50-60秒，混合转速为30-40转/分钟。
采用上述进一步技术方案的有益效果：准确的混合参数使原料混合均匀，保护肠胃的奶粉产品质量均一稳定。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
保护肠胃的奶粉的制备方法，包括以下步骤：
(1)称取脱脂奶粉600克，全脂奶粉150克，牛初乳粉50克，固体玉米糖浆2克，乳糖2克，低聚半乳糖1克，乳铁蛋白0.3克，牛磺酸0.2克，复合益生菌冻干粉0.2克，复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，动物双歧杆菌的含量为1×106CFU/g，嗜酸乳杆菌的含量为1×106CFU/g，复合维生素以100g保护肠胃的奶粉计包括：L-抗坏血酸钠25mg，dl-α-醋酸生育酚15mg，醋酸维生素A0.5mg，胆钙化醇6μg，盐酸吡哆醇0.8mg，复合矿物质以100g所述保护肠胃的奶粉计包括：焦磷酸铁2mg，硫酸锌10mg；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸、复合矿物质混合均匀，混合时间为20分钟，混合转速为50转/分钟，然后粉碎至过60目筛，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉、复合维生素加入预混粉中，混合均匀，混合时间为50秒，混合转速为30转/分钟，制得所述保护肠胃的奶粉。
实施例2
保护肠胃的奶粉的制备方法，包括以下步骤：
(1)称取脱脂奶粉700克，全脂奶粉180克，牛初乳粉70克，固体玉米糖浆3克，乳糖3克，低聚半乳糖2克，乳铁蛋白0.4克，牛磺酸0.3克，复合益生菌冻干粉1克，复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，动物双歧杆菌的含量为1×106CFU/g，嗜酸乳杆菌的含量为1×106CFU/g，复合维生素以100g保护肠胃的奶粉计包括：L-抗坏血酸钠55mg，dl-α-醋酸生育酚30mg，醋酸维生素A0.6mg，胆钙化醇10μg，盐酸吡哆醇1.1mg，复合矿物质以100g所述保护肠胃的奶粉计包括：焦磷酸铁3mg，硫酸锌12mg；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸、复合矿物质混合均匀，混合时间为25分钟，混合转速为55转/分钟，然后粉碎至过60目筛，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉、复合维生素加入预混粉中，混合均匀，混合时间为55秒，混合转速为35转/分钟，制得所述保护肠胃的奶粉。
实施例3
保护肠胃的奶粉的制备方法，包括以下步骤：
(1)称取脱脂奶粉800克，全脂奶粉200克，牛初乳粉100克，固体玉米糖浆5克，乳糖5克，低聚半乳糖3克，乳铁蛋白0.7克，牛磺酸0.5克，复合益生菌冻干粉2克，复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，动物双歧杆菌的含量为1×107CFU/g，嗜酸乳杆菌的含量为1×107CFU/g，复合维生素以100g保护肠胃的奶粉计包括：L-抗坏血酸钠98mg，dl-α-醋酸生育酚45mg，醋酸维生素A0.8mg，胆钙化醇12μg，盐酸吡哆醇1.5mg，复合矿物质以100g所述保护肠胃的奶粉计包括：焦磷酸铁4mg，硫酸锌15mg；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸、复合矿物质混合均匀，混合时间为30分钟，混合转速为60转/分钟，然后粉碎至过70目筛，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉、复合维生素加入预混粉中，混合均匀，混合时间为60秒，混合转速为40转/分钟，制得所述保护肠胃的奶粉。
实施例4
保护肠胃的奶粉的制备方法，包括以下步骤：
(1)称取脱脂奶粉600克，全脂奶粉150克，牛初乳粉50克，固体玉米糖浆2克，乳糖2克，低聚半乳糖1克，乳铁蛋白0.3克，牛磺酸0.2克，复合益生菌冻干粉0.2克，复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，动物双歧杆菌的含量为1×106CFU/g，嗜酸乳杆菌的含量为1×106CFU/g；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸混合均匀，混合时间为20分钟，混合转速为50转/分钟，然后粉碎至过60目筛，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉加入预混粉中，混合均匀，混合时间为50秒，混合转速为30转/分钟，制得所述保护肠胃的奶粉。
实施例5
保护肠胃的奶粉的制备方法，包括以下步骤：
(1)称取脱脂奶粉700克，全脂奶粉180克，牛初乳粉70克，固体玉米糖浆3克，乳糖3克，低聚半乳糖2克，乳铁蛋白0.4克，牛磺酸0.3克，复合益生菌冻干粉1克，复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，动物双歧杆菌的含量为1×106CFU/g，嗜酸乳杆菌的含量为1×106CFU/g；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸混合均匀，混合时间为25分钟，混合转速为55转/分钟，然后粉碎至过60目筛，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉加入预混粉中，混合均匀，混合时间为55秒，混合转速为35转/分钟，制得所述保护肠胃的奶粉。
实施例6
保护肠胃的奶粉的制备方法，包括以下步骤：
(1)称取脱脂奶粉800克，全脂奶粉200克，牛初乳粉100克，固体玉米糖浆5克，乳糖5克，低聚半乳糖3克，乳铁蛋白0.7克，牛磺酸0.5克，复合益生菌冻干粉2克，复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，动物双歧杆菌的含量为1×107CFU/g，嗜酸乳杆菌的含量为1×107CFU/g；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸混合均匀，混合时间为30分钟，混合转速为60转/分钟，然后粉碎至过70目筛，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉加入预混粉中，混合均匀，混合时间为60秒，混合转速为40转/分钟，制得所述保护肠胃的奶粉。
以实施例3保护肠胃的奶粉为例，营养成分见表1：
表1
效果实验：
挑选男性50例，女性50例，年龄为18-50岁，分成两组，每组男性25例，女性25例，两组研究对象年龄比例分布均衡，试验组食用实施例3奶粉，每天早中晚各食用100克奶粉，对照组不食用奶粉，观察天数为10天，实验前后，都没有发现其他的不良反应。
观察两组实验人员的粪便频率、性状、颜色，作为评估分析指标，试验结果：
1、粪便情况：
对照组：大便总次数1125次，人均2.25次/天，其中糊状便489次(占43.5％)，黄软便396次(占35.2％)，成形便112次(占10.0％)，稀水样便128次(占11.38％)。
试验组：大便总次数1825次，人均3.65次/天，其中糊状便963次(占56.65％)，黄软便786次(42.96％)，成形便46次(占1.82％)，稀水样便30次(占0.91％)。
详见表2；
表2
| 大便性状 | 糊状便 | 黄软便 | 成形便 | 稀水样便 |
| 试验组 | 56.65％ | 42.96％ | 1.82％ | 0.91％ |
| 对照组 | 43.5％ | 35.2％ | 10.0％ | 11.38％ |
从表2可以看出，食用本发明奶粉后，食用者的平均每日大便次数明显较高，糊状便、黄软便比例显著较高，稀水样便与成形便显著比例较小，因此本发明保护肠胃的奶粉对于改善肠道健康与通畅，促进腹泻康复的效果明显。
实施例1-2的试验结果结论与实施例3相同，不再赘述，对所公开的实施例的说明，使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的，本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下，在其它实施例中实现。因此，本发明将不会被限制于本文所示的这些实施例，而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (9)
1.一种保护肠胃的奶粉，其特征在于，包括以下重量份的原料：脱脂奶粉600-800份，全脂奶粉150-200份，牛初乳粉50-100份，固体玉米糖浆2-5份，乳糖2-5份，低聚半乳糖1-3份，乳铁蛋白0.3-0.7份，牛磺酸0.2-0.5份，复合益生菌冻干粉0.2-2份；
所述复合益生菌冻干粉包括动物双歧杆菌和嗜酸乳杆菌，所述动物双歧杆菌的含量为1×106-1×107CFU/g，所述嗜酸乳杆菌的含量为1×106-1×107CFU/g。
2.根据权利要求1所述一种保护肠胃的奶粉，其特征在于，还包括：复合维生素，以100g所述保护肠胃的奶粉计，所述复合维生素包括：L-抗坏血酸钠25-98mg，dl-α-醋酸生育酚15-45mg，醋酸维生素A0.5-0.8mg，胆钙化醇6-12μg，盐酸吡哆醇0.8-1.5mg。
3.根据权利要求1所述一种保护肠胃的奶粉，其特征在于，还包括：复合矿物质，以100g所述保护肠胃的奶粉计，所述复合矿物质包括：焦磷酸铁2-4mg，硫酸锌10-15mg。
4.一种保护肠胃的奶粉的制备方法，其特征在于，包括以下步骤：
(1)按照权利要求1-3任一项所述一种保护肠胃的奶粉称取各原料；
(2)将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸混合均匀，然后粉碎，制得预混粉；
(3)将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉加入预混粉中，混合均匀，制得所述保护肠胃的奶粉。
5.根据权利要求4所述一种保护肠胃的奶粉的制备方法，其特征在于，所述步骤(2)为：将固体玉米糖浆、乳糖、低聚半乳糖、乳铁蛋白、牛磺酸、复合矿物质混合均匀，然后粉碎，制得预混粉。
6.根据权利要求5所述一种保护肠胃的奶粉的制备方法，其特征在于，所述步骤(2)中，混合时间为20-30分钟，混合转速为50-60转/分钟。
7.根据权利要求5所述一种保护肠胃的奶粉的制备方法，其特征在于，所述步骤(2)中，粉碎至过60-70目筛。
8.根据权利要求4所述一种保护肠胃的奶粉的制备方法，其特征在于，所述步骤(3)为：将脱脂奶粉、全脂奶粉、牛初乳粉、复合益生菌冻干粉、复合维生素加入预混粉中，混合均匀，制得所述保护肠胃的奶粉。
9.根据权利要求8所述一种保护肠胃的奶粉的制备方法，其特征在于，所述步骤(3)中，混合时间为50-60秒，混合转速为30-40转/分钟。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110112958.XA CN112753776A (zh) | 2021-01-27 | 2021-01-27 | 一种保护肠胃的奶粉及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110112958.XA CN112753776A (zh) | 2021-01-27 | 2021-01-27 | 一种保护肠胃的奶粉及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112753776A true CN112753776A (zh) | 2021-05-07 |
Family
ID=75706236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110112958.XA Pending CN112753776A (zh) | 2021-01-27 | 2021-01-27 | 一种保护肠胃的奶粉及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112753776A (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104757123A (zh) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | 一种全干混婴幼儿配方奶粉及其制备方法 |
| CN111264623A (zh) * | 2020-03-26 | 2020-06-12 | 湖南多能多食品有限公司 | 一种促进儿童生长发育的奶粉及其制备方法 |
| CN111466443A (zh) * | 2020-04-14 | 2020-07-31 | 周赛新 | 一种儿童成长营养奶粉 |
-
2021
- 2021-01-27 CN CN202110112958.XA patent/CN112753776A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104757123A (zh) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | 一种全干混婴幼儿配方奶粉及其制备方法 |
| CN111264623A (zh) * | 2020-03-26 | 2020-06-12 | 湖南多能多食品有限公司 | 一种促进儿童生长发育的奶粉及其制备方法 |
| CN111466443A (zh) * | 2020-04-14 | 2020-07-31 | 周赛新 | 一种儿童成长营养奶粉 |
Non-Patent Citations (3)
| Title |
|---|
| 吴少雄等: "《营养学》", 28 February 2018, 中国质检出版社 * |
| 孙树侠等: "《牛初乳与营养免疫》", 30 September 2016, 中国医药科技出版社 * |
| 生庆海等: "《乳粉分析与检测技术》", 31 March 2010, 中国轻工业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6929793B2 (en) | Nutritional composition for treating an immune condition | |
| Buttriss | Nutritional properties of fermented milk products | |
| DE60116112T2 (de) | Ernährungszusammensetzung | |
| CN107594279A (zh) | 一种益生菌粉固体饮料及其制备方法 | |
| AU2002221860A1 (en) | Nutritional composition for an immune condition | |
| CN101564133B (zh) | 一种豆酸奶及其制造方法 | |
| JP5864676B2 (ja) | 貧血の予防又は治療用組成物 | |
| CN112535283A (zh) | 一种全营养配方粉 | |
| CN113826692A (zh) | 一种益生菌固体饮料及其制备方法 | |
| CN109430407A (zh) | 益生菌组合制剂 | |
| CN110338402A (zh) | 一种复合益生菌粉及其制备方法 | |
| JP4231208B2 (ja) | 骨粗鬆症の予防のための発酵乳由来の栄養補助食品 | |
| Chandan | Role of milk and dairy foods in nutrition and health | |
| WO2021149663A1 (ja) | 組成物 | |
| JP4336930B2 (ja) | 乳酸菌発酵液の製造方法及び該発酵液を原料とする食品 | |
| CN109588602A (zh) | 一种益生菌固体饮料 | |
| CN114190441A (zh) | 一种促进儿童身高发育的配方奶粉及其制备方法 | |
| JP6037595B2 (ja) | 満腹感誘導組成物及びその製造方法 | |
| CN110679663A (zh) | 一种儿童营养奶粉及其制备方法 | |
| CN112753776A (zh) | 一种保护肠胃的奶粉及其制备方法 | |
| CN114947138A (zh) | 一种预防与改善钙缺乏病的乳钙组合物、其制法及应用 | |
| CN112753775A (zh) | 一种抗发炎的奶粉及其制备方法 | |
| WO2021093880A1 (zh) | 产丁酸的益生元益生菌增效组合 | |
| CN111328949A (zh) | 一种b族维生素组合物固体饮料 | |
| CN104222272A (zh) | 浒苔益生菌饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210507 |